Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanofi-aventis US, Merck sign R&D pact
The novel combinations involve Merck Serono‘s MEK inhibitor MSC1936369B (also known as AS703026), Sanofi-aventis PI3K/mTOR inhibitor SAR245409 (also known as XL765) and class I PI3K inhibitor SAR245408 (also
The novel combinations involve Merck Serono‘s MEK inhibitor MSC1936369B (also known as AS703026), Sanofi-aventis PI3K/mTOR inhibitor SAR245409 (also known as XL765) and class I PI3K inhibitor SAR245408 (also
iSOFT Group has moved into the life science space with solutions that extract and de-identify clinical data from electronic medical records for clinical research and other secondary uses
The new funding follows the positive results demonstrated during the OLNORME (Occurrence of novel Ligands for a Nuclear Orphan Receptor in plant Metabolites) programme, initiated in 2006. During
The Scopius-5 database platform stores many details of selected compounds such as: multiple-conformation 3D models, shape and charge descriptors, property values and compound availability information, and/or synthetic route
In addition, 3M has IRMs available for license in the areas of cancer, asthma/allergy and as vaccine adjuvants. 3M Drug Delivery Systems Vaccine Business Development director Mark Tomai
Under the terms of the agreement, Recordati receives exclusive rights to develop and subsequently market and sell NX-1207 in Europe including Russia and the CIS, the Middle East,
NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus.Neuralstem president and CEO Richard Garr said that the commencement of
In November, the company reported that it had received a question from the FDA regarding chemistry, manufacturing and controls (CMC) that has now been resolved. Preclinical studies of
Under the terms of agreement, GSK will obtain an exclusive license to commercialize IPX066 throughout the world, except in the US and Taiwan. Impax will receive an upfront
Catalyst and Wyeth LLC (the successor to Wyeth), a wholly owned subsidiary of Pfizer, formed an exclusive, worldwide collaboration for the discovery, development and commercialization of improved, second